Nov 05, 2021 07:48 PM (GMT+8) · EqualOcean
Financial Associated Press, Nov. 5 - Samsung Medical announced that it had purchased 84% equity of Hangzhou Mingzhou rehabilitation and 85% equity of Nanchang Mingzhou rehabilitation with RMB 397 million and RMB 119 million respectively for the rehabilitation investment of its wholly-owned subsidiary. Recently, Hangzhou Mingzhou rehabilitation and Nanchang Mingzhou rehabilitation completed the industrial and commercial change registration procedures related to equity transfer. After the completion of the industrial and commercial change, the rehabilitation investment of the company's wholly-owned subsidiary will directly hold 84% equity of Hangzhou Mingzhou rehabilitation and 85% equity of Nanchang Mingzhou rehabilitation. Hangzhou Mingzhou rehabilitation and Nanchang Mingzhou rehabilitation will be included in the scope of the company's consolidated statements.

This text is a result of machine translation.